OPEN Health Acquires Life Science Advisory Firm Ascel

Acsel Health is a life science advisory and strategy company with offices in New York and has recently been bought by OPEN Health.

Acsel’s high performing record of accomplishment in offering premium, quality partnerships to life science firms are driven by its in-depth industry knowledge, thorough scientific approach, and practical insight.

These characteristics will enhance OPEN Health’s current model and increase the number of solutions it can provide to pharmaceutical and biotechnology firms.

Managing Partner of Acsel, Lujing Wang, explained how they see the acquisition being able to “solve today’s demands and meet tomorrow’s expectations for pharma and biotech customers.”

She continued: “We are equipped to answer the most challenging cross-disciplinary questions in life science across all key therapeutic areas.”

OPEN Health’s Chief Executive Officer, Rob Barker, explained that “Acsel’s expert team and long-standing client relationships significantly strengthen our ability to support the commercialization of our clients’ assets and unlock access for patients.”

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.